Healthcare Systems Embrace Pharmacogenomics to Minimize Adverse Drug Reactions and Optimize Drug Efficacy
The global pharmacogenomics technologies market size and share was valued at USD 8.17 billion in 2024 and is expected to grow at a CAGR of 8.3% during the forecast period. In North America the market is driven by rapid adoption of precision medicine, strong research funding, and established clinical-genomics infrastructure, giving it a leading position in this high-growth arena. Regional...
0 Reacties 0 aandelen 7 Views 0 voorbeeld